![Mark C. Warburton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark C. Warburton
Director/Board Member at Apex Molecular Ltd.
Profile
Mark C.
Warburton is a Non-Executive Director at Apex Molecular Ltd.
He was a Non-Executive Director at LSL Property Services Plc from 2006 to 2009.
He was also the COO, Secretary, Legal Counsel & IR Contact at Cyprotex Ltd.
from 2012 to 2017.
Additionally, he worked at Addleshaw Booth & Co. from 2004 to 2007.
Mark C. Warburton active positions
Companies | Position | Start |
---|---|---|
Apex Molecular Ltd.
![]() Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Director/Board Member | - |
Former positions of Mark C. Warburton
Companies | Position | End |
---|---|---|
CYPROTEX PLC | Chief Operating Officer | 2017-06-29 |
LSL PROPERTY SERVICES PLC | Director/Board Member | 2009-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
LSL PROPERTY SERVICES PLC | Finance |
Private companies | 2 |
---|---|
Cyprotex Ltd.
![]() Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Apex Molecular Ltd.
![]() Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mark C. Warburton